Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200

Standard

Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200. / Yusuf, Imran H; Birtel, Johannes; Shanks, Morag E; Clouston, Penny; Downes, Susan M; Charbel Issa, Peter; MacLaren, Robert E.

In: JAMA OPHTHALMOL, Vol. 137, No. 11, 01.11.2019, p. 1295-1300.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Yusuf, IH, Birtel, J, Shanks, ME, Clouston, P, Downes, SM, Charbel Issa, P & MacLaren, RE 2019, 'Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200', JAMA OPHTHALMOL, vol. 137, no. 11, pp. 1295-1300. https://doi.org/10.1001/jamaophthalmol.2019.3298

APA

Yusuf, I. H., Birtel, J., Shanks, M. E., Clouston, P., Downes, S. M., Charbel Issa, P., & MacLaren, R. E. (2019). Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200. JAMA OPHTHALMOL, 137(11), 1295-1300. https://doi.org/10.1001/jamaophthalmol.2019.3298

Vancouver

Bibtex

@article{dd29ad408cb34162aaa67f2ec26410ab,
title = "Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200",
abstract = "IMPORTANCE: SNRNP200 is a recently identified genetic cause of autosomal dominant retinitis pigmentosa (RP). However, the associated retinal phenotype is not well characterized.OBJECTIVE: To describe the retinal phenotype in patients with RP secondary to variants in SNRNP200.DESIGN, SETTING, AND PARTICIPANTS: This retrospective, case-series study was performed at 2 tertiary referral centers for inherited retinal diseases. Participants included 9 consecutive patients from 8 families with RP attributed to variants in SNRNP200. Data were collected from August 2017 to March 2018 and analyzed from May to July 2018.MAIN OUTCOMES AND MEASURES: Results of clinical evaluation, multimodal retinal imaging, and molecular genetic testing using targeted next-generation sequencing.RESULTS: Of the 9 patients included in the analysis (4 female and 5 male; mean [SD] age at presentation, 19 [15] years), each presented with nyctalopia, typically in the first 2 decades of life, although 2 patients experienced symptom onset in middle age. None had any consistent systemic features suggestive of syndromic RP. Retinal imaging studies and electroretinography findings were typical of a rod-predominant dystrophy with later involvement of cone photoreceptors. Phenotypic heterogeneity was typified by 4 unrelated patients with the common c.2041C>T SNRNP200 variant who demonstrated a variable age of disease onset (middle teenage years to the fourth decade of life). Disease progression was slow, with all but 1 patient maintaining visual acuity of better than 20/40 in the better-seeing eye in the fifth and sixth decades of life.CONCLUSIONS AND RELEVANCE: These data suggest that variants in SNRNP200 result in nonsyndromic RP with a typical phenotype of a rod-predominant dystrophy. Significant phenotypic heterogeneity and nonpenetrance were noted within some affected families. Symptom onset was typically within the first 2 decades of life, with slow progression and well-preserved visual acuities into the fifth and sixth decades.",
author = "Yusuf, {Imran H} and Johannes Birtel and Shanks, {Morag E} and Penny Clouston and Downes, {Susan M} and {Charbel Issa}, Peter and MacLaren, {Robert E}",
year = "2019",
month = nov,
day = "1",
doi = "10.1001/jamaophthalmol.2019.3298",
language = "English",
volume = "137",
pages = "1295--1300",
journal = "JAMA OPHTHALMOL",
issn = "2168-6165",
publisher = "American Medical Association",
number = "11",

}

RIS

TY - JOUR

T1 - Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200

AU - Yusuf, Imran H

AU - Birtel, Johannes

AU - Shanks, Morag E

AU - Clouston, Penny

AU - Downes, Susan M

AU - Charbel Issa, Peter

AU - MacLaren, Robert E

PY - 2019/11/1

Y1 - 2019/11/1

N2 - IMPORTANCE: SNRNP200 is a recently identified genetic cause of autosomal dominant retinitis pigmentosa (RP). However, the associated retinal phenotype is not well characterized.OBJECTIVE: To describe the retinal phenotype in patients with RP secondary to variants in SNRNP200.DESIGN, SETTING, AND PARTICIPANTS: This retrospective, case-series study was performed at 2 tertiary referral centers for inherited retinal diseases. Participants included 9 consecutive patients from 8 families with RP attributed to variants in SNRNP200. Data were collected from August 2017 to March 2018 and analyzed from May to July 2018.MAIN OUTCOMES AND MEASURES: Results of clinical evaluation, multimodal retinal imaging, and molecular genetic testing using targeted next-generation sequencing.RESULTS: Of the 9 patients included in the analysis (4 female and 5 male; mean [SD] age at presentation, 19 [15] years), each presented with nyctalopia, typically in the first 2 decades of life, although 2 patients experienced symptom onset in middle age. None had any consistent systemic features suggestive of syndromic RP. Retinal imaging studies and electroretinography findings were typical of a rod-predominant dystrophy with later involvement of cone photoreceptors. Phenotypic heterogeneity was typified by 4 unrelated patients with the common c.2041C>T SNRNP200 variant who demonstrated a variable age of disease onset (middle teenage years to the fourth decade of life). Disease progression was slow, with all but 1 patient maintaining visual acuity of better than 20/40 in the better-seeing eye in the fifth and sixth decades of life.CONCLUSIONS AND RELEVANCE: These data suggest that variants in SNRNP200 result in nonsyndromic RP with a typical phenotype of a rod-predominant dystrophy. Significant phenotypic heterogeneity and nonpenetrance were noted within some affected families. Symptom onset was typically within the first 2 decades of life, with slow progression and well-preserved visual acuities into the fifth and sixth decades.

AB - IMPORTANCE: SNRNP200 is a recently identified genetic cause of autosomal dominant retinitis pigmentosa (RP). However, the associated retinal phenotype is not well characterized.OBJECTIVE: To describe the retinal phenotype in patients with RP secondary to variants in SNRNP200.DESIGN, SETTING, AND PARTICIPANTS: This retrospective, case-series study was performed at 2 tertiary referral centers for inherited retinal diseases. Participants included 9 consecutive patients from 8 families with RP attributed to variants in SNRNP200. Data were collected from August 2017 to March 2018 and analyzed from May to July 2018.MAIN OUTCOMES AND MEASURES: Results of clinical evaluation, multimodal retinal imaging, and molecular genetic testing using targeted next-generation sequencing.RESULTS: Of the 9 patients included in the analysis (4 female and 5 male; mean [SD] age at presentation, 19 [15] years), each presented with nyctalopia, typically in the first 2 decades of life, although 2 patients experienced symptom onset in middle age. None had any consistent systemic features suggestive of syndromic RP. Retinal imaging studies and electroretinography findings were typical of a rod-predominant dystrophy with later involvement of cone photoreceptors. Phenotypic heterogeneity was typified by 4 unrelated patients with the common c.2041C>T SNRNP200 variant who demonstrated a variable age of disease onset (middle teenage years to the fourth decade of life). Disease progression was slow, with all but 1 patient maintaining visual acuity of better than 20/40 in the better-seeing eye in the fifth and sixth decades of life.CONCLUSIONS AND RELEVANCE: These data suggest that variants in SNRNP200 result in nonsyndromic RP with a typical phenotype of a rod-predominant dystrophy. Significant phenotypic heterogeneity and nonpenetrance were noted within some affected families. Symptom onset was typically within the first 2 decades of life, with slow progression and well-preserved visual acuities into the fifth and sixth decades.

U2 - 10.1001/jamaophthalmol.2019.3298

DO - 10.1001/jamaophthalmol.2019.3298

M3 - SCORING: Journal article

C2 - 31486839

VL - 137

SP - 1295

EP - 1300

JO - JAMA OPHTHALMOL

JF - JAMA OPHTHALMOL

SN - 2168-6165

IS - 11

ER -